ホーム>>Nucleotides/Nucleosides>>Adenosine 3’-monophosphate (sodium salt hydrate)

Adenosine 3’-monophosphate (sodium salt hydrate) (Synonyms: 3’-AMP)

カタログ番号GC49004

ヌクレオチド

Products are for research use only. Not for human use. We do not sell to patients.

Adenosine 3’-monophosphate (sodium salt hydrate) 化学構造

Cas No.: N/A

サイズ 価格 在庫数 個数
50 mg
$60.00
在庫あり
100 mg
$108.00
在庫あり
250 mg
$255.00
在庫あり

Tel:(909) 407-4943 Email: sales@glpbio.com

顧客レビュー

カスタマーレビューに基づきます。

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents

Adenosine 3’-monophosphate is a nucleotide and metabolite formed via hydrolysis of 2’,3’-cAMP by metal-dependent phosphodiesterases.1 It reduces proliferation of rat preglomerular vascular smooth muscles cells (PGVSMCs) and glomerular mesangial cells (GMCs) in a concentration-dependent manner, an effect that is abolished by the adenosine A2B receptor antagonist MRS1754.2 Adenosine 3’-monophosphate is also a metabolic intermediate in the biosynthesis of adenosine .

1.Rao, F., Yaning, Q., Murugan, E., et al.20,30-cAMP hydrolysis bymetal-dependent phosphodiesterases containing DHH, EAL, and HD domains is non-specific: Implications for PDE screeningBiochem. Bioph. Res. Commun.398(3)500-505(2010) 2.Jackson, E.K., Gillespie, D.G., and Dubey, R.K.2’-AMP and 3’-AMP inhibit proliferation of preglomerular vascular smooth muscle cells and glomerular mesangial cells via A2B receptorsJ. Pharmacol. Exp. Ther.337(2)444-450(2011)

レビュー

Review for Adenosine 3’-monophosphate (sodium salt hydrate)

Average Rating: 5 ★★★★★ (Based on Reviews and 14 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for Adenosine 3’-monophosphate (sodium salt hydrate)

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.